Latanoprost/Timolol Aurobindo

Timolol maleate and latanoprost, the active ingredients in Latanoprost/Timolol Aurobindo, are a beta‑blocker/prostaglandin analog combination presented as an ophthalmic solution for ocular use. It treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other global markets. The company adheres to stringent quality standards and provides regulatory support for importation. Customers benefit from reliable logistics, batch traceability, and responsive technical assistance throughout the supply chain.

Latanoprost/Timolol is indicated for ocular conditions where reduction of intra‑ocular pressure is required, primarily within the glaucoma therapeutic pathway.

- Open‑angle glaucoma: lowers intra‑ocular pressure to slow disease progression. - Ocular hypertension: reduces elevated eye pressure to prevent conversion to glaucoma. - Secondary ocular hypertension: helps control pressure when caused by other ocular conditions. - Mixed‑mechanism glaucoma: provides dual action to achieve target pressure when monotherapy is insufficient.

Adverse reactions to Latanoprost/Timolol may involve ocular and systemic manifestations, varying in frequency and severity.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Blurred vision: temporary visual disturbance. - Conjunctival hyperemia: redness of the eye. - Dry eye: decreased tear production.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Persistent eye pain: may indicate corneal involvement.

When prescribing Latanoprost/Timolol, clinicians should consider several precautionary measures to ensure safe and effective use. - Assess cardiovascular status: avoid in patients with severe bradycardia or heart block. - Evaluate respiratory conditions: use with caution in asthma or chronic obstructive pulmonary disease. - Monitor intra‑ocular pressure: check response and adjust therapy as needed. - Consider ocular surface disease: patients with severe dry eye may experience discomfort. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep the bottle in its original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines, altering its efficacy or increasing adverse effects.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol): additive systemic beta‑blockade may cause bradycardia or hypotension. - Other ocular hypotensive agents: excessive IOP reduction can lead to ocular hypotony.

Moderate Interactions (Monitor Closely): - Systemic beta‑blockers: monitor heart rate and blood pressure. - Calcium channel blockers: may enhance ocular hypotensive effect. - Anticholinergic eye drops: could affect pupil size and drug absorption.